Bionano Presents OGM Utility Across Stem Cell Therapy Applications At The ISSCR Annual Meeting
Portfolio Pulse from Benzinga Newsdesk
Bionano Genomics, Inc. (NASDAQ:BNGO) will present on the utility of optical genome mapping (OGM) in stem cell therapy at the ISSCR Annual Meeting 2024. The presentation will feature experts from Ruhr University Bochum, Scripps Research Institute, and Bionano. Two scientific posters on OGM applications in cell manufacturing and bioprocessing will also be showcased.

July 02, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bionano Genomics will present on the utility of optical genome mapping (OGM) in stem cell therapy at the ISSCR Annual Meeting 2024, highlighting its applications in research, development, and manufacturing.
The presentation at a major conference like ISSCR can increase visibility and credibility for Bionano's OGM technology, potentially leading to increased interest and adoption in the stem cell therapy sector. This could positively impact BNGO's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100